“Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s711. doi:10.25251/36mxmk39.